Your session is about to expire
← Back to Search
Prebiotics for Peanut Allergy
Study Summary
This trial is testing whether adding a prebiotic to peanut oral immunotherapy is safe and effective. The prebiotic is a type of fiber found in grocery stores, not an FDA-approved drug.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this study allow for participants who are older than 25 years of age?
"To be eligible for this clinical trial, applicants must be aged 4 to 17. Out of the 248 total studies, 86 are geared towards children while 162 are for adults over 65."
Are we still able to include new test subjects in this research?
"The clinical trial is recruiting patients, with the most recent update to the posting on clinicaltrials.gov being on March 1st, 2022. The study was originally posted on November 30th, 2021."
Who can sign up for this experiment?
"This clinical trial is enrolling 30 participants with peanut allergies aged 4 and 17. Most notable, patients should meet the following criteria: -Age 4 to 17 (inclusive)-A convincing clinical history of peanut allergy -Serum IgE to peanut of >14 kUA/L and mean peanut wheal diameter on skin prick test 3mm greater than the negative saline control -Written informed consent from parent/guardian -Written assent from subjects above the age of 7 -Immune markers consistent with peanut allergy (-or-) -Serum IgE to peanut"
How many people have signed up for this experiment so far?
"That is correct. According to the information available on clinicaltrials.gov, this trial posted on 11/30/2021 and edited on 3/1/2022 is still recruiting patients. They are looking for 30 individuals to participate at 2 locations."
Share this study with friends
Copy Link
Messenger